Should you buy Shockwave medical (swav) stock?

ShockWave Medical, Inc. SWAV is well-poised for growth, backed by its research and development (R&D) efforts and focus on clinical studies. Shares of this Zacks Rank #1 (Strong Buy) stock have gained 55.8% against the industry ’s decline of 34.3% so far this year. The S&P 500 Index has fallen 21.2% in the same time frame.

Who is Shockwave medical?

SANTA CLARA, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- January 8, 2024 – Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for...

Who owns Shockwave medical?

The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA. The Fool has written over 100 articles on Shockwave Medical. Buyout rumors and love from Wall Street propelled the stock to double-digit gains.